Vical's IPO

Vical raised a round of funding on , . Investors include Public.

Vical, Inc. develops biopharmaceutical products based on our patented naked DNA gene transfer technologies for the prevention and treatment of life-threatening diseases. We currently focus our develop…

Articles about Vical's IPO: